Detalles de la búsqueda
1.
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies.
Ther Adv Med Oncol
; 14: 17588359221087555, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35432603
Resultados
1 -
1
de 1
1
Próxima >
>>